"Today, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019"
8 months later and here we are, well done @pfizer@BioNTech_Groupfda.gov/news-events/pr…
$BNTX BioNTech
Pfizer agreed to take on all development costs until commercialisation.
$748 million initial deal with Pfizer. BioNTech is in bed with almost every other big pharma player. evaluate.com/vantage/articl…
Down on monthly average. What don't we know?
I am glad to hear #VRBPAC voted 17-4 in support of the @US_FDA granting EUA for our #COVID19 vaccine. We look forward to a final FDA decision coming soon & stand ready to begin delivering the first batch of doses immediately, if we receive authorization. pfizer.com/news/press-rel…
Some $PFE $40 calls Friday were selling @ 0.08. Opened at $3... x40 return if anyone was lucky enough to perfect the timing mentioned in my tweet.
Other key dates to watch out for
@RNAiAnalyst I plan to play PFE calls around the events, to limit market exposure. Basing my plan on Bourla's open letter "we may know whether or not our vaccine is effective by the end of October"
pfizer.com/news/hot-topic…
Expecting:
Efficacy 1st-2nd week of Nov
Safety data 3rd
EUA sub 4th
In short, it's a good sign the 32 infectious milestone (0.1% group infection rate) hasn't been reached sooner than expected, as points to higher efficacy in non-placebo group
Based on quotes and high general population infection rates over last month, we are very close to data
"Efficacy results for Pfizer-partnered Covid-19 vaccine are coming soon - if not within the next couple of days then early November" Sahin VRM interview from 7 days go, so expecting $PFE $BNTX data next week at the latest. Bourla's open letter also referenced end of Oct
In short, it's a good sign the 32 infectious milestone (0.1% group infection rate) hasn't been reached sooner than expected, as points to higher efficacy in non-placebo group
Based on quotes and high general population infection rates over last month, we are very close to data
So assuming 15k placebo group is US based (only partial) where high infection prevalent the milestone should've been reached on time (.21% vs .75%). Note trial volunteers less likely to engage in higher risk activities, so that and subject test/retesting rate also factors
"Efficacy results for Pfizer-partnered Covid-19 vaccine are coming soon - if not within the next couple of days then early November" Sahin VRM interview from 7 days go, so expecting $PFE $BNTX data next week at the latest. Bourla's open letter also referenced end of Oct
Don't miss yesterday's #Covid19 roundup: BioNTech CEO Ugur Sahin is still optimistic that the first efficacy results for its Pfizer-partnered vaccine are coming “soon” — if not within the next couple of days then early November.
endpts.com/covid-19-round…
@RNAiAnalyst I plan to play PFE calls around the events, to limit market exposure. Basing my plan on Bourla's open letter "we may know whether or not our vaccine is effective by the end of October"
pfizer.com/news/hot-topic…
Expecting:
Efficacy 1st-2nd week of Nov
Safety data 3rd
EUA sub 4th
Update 1 (missing from main list)
$SBPH NIH compound feedback
$ASTC updates on breathalyzers for covid detection
$IDXG Covid19 lab testing service
$AIM Ampligen trial starting / updates
With thanks to @Higgins14Steve and aveyn on atlas
BREAKING: Johnson & Johnson’s #COVID19 vaccine trial of 60,000 has been suddenly paused due to a new unexplained illness. Study enrollment website also frozen while DSMB (data safety monitoring board) reviews. to be updated. statnews.com/2020/10/12/joh…
@MaxCRoser@UniofOxford Just make sure @UniofOxford stop the @AstraZeneca covid-19 trials before more people get hurt in the UK, much better options out there in terms of safety. Will be catastrophic for public confidence in vaccines, if one with suspected neurological side effects is approved.
@DipDeity He hurts a lot of new investors, regularly providing opinions with little research or scientific backing. He attempted to roast me 2 weeks ago exposing faults with $ABT's test, this week, entire White House covid-19 positive because of these very tests
@AMAPCEO_member@jimcramer Tried to explain to @jimcramer last week. People like him pushing tests as accurate, that are not accurate are the problem unfortunately. There's a long way to go with testing and none are accurate in early stages
@TLNanoMed @RNAiAnalyst $BNTX seem upfront about it:
"The SARS-CoV-2 neutralization assay used a previously described strain of SARS-CoV-2 (USA_WA1/2020) that had been rescued by reverse genetics and engineered by the insertion of an mNeonGreen"
investors.biontech.de/static-files/4…
Anyone got a link to court case?
318 Followers 1K FollowingThey/them/him. 🧘🏾♂️ Kind. Homo Sapien Sapien with a keyboard. Soy persona. Turbo Autistic with 99.9% confidence. Retweets not endorsements. #MindfulL
2K Followers 5K FollowingMadre, mujer y emprendedora. Antisocialista hasta lo más profundo de mi ser. Fiel creyente de que los buenos somos más y podemos sacar al Ecuador adelante.
537 Followers 2K FollowingNo investment recommedations. No financial advices. Do your own Due Diligence. Tweets are for my own education and entertainment only.
1K Followers 581 FollowingContributing writer at Potential Multibaggers on SeekingAlpha. No investing advice here, it’s all just my thoughts and opinions for learning and fun.